Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Ballif, Marie ^a,b   Harino, Paul ^c   Ley, Serej ^a,b,c   Coscolla, Mireia ^a,b   Niemann, Stefan ^d   Carter, Robyn ^e   Coulter, Christopher ^e   Borrell, Sonia ^a,b   Siba, Peter ^c   Phuanukoonnon, Suparat ^c   Gagneux, Sebastien ^a,b   Beck, Hans Peter ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^d RESEARCH CENTER BORSTEL   (Germany)

^e Queensland Mycobacterium Reference Laboratory   (Australia)

Author keywords

Drug resistance; Mutations; Mycobacterium tuberculosis; Papua New Guinea

Indexed keywords

AMINOSALICYLIC ACID; ETHIONAMIDE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CLINICAL TRIAL; GENE MUTATION; HUMAN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PAPUA NEW GUINEA; PHENOTYPE;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; PAPUA NEW GUINEA; PILOT PROJECTS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84865615933     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-191     Document Type: Article

References (33)

1. World Health Organization, Tuberculosis country profile Guinea: Papua New Guinea 2011
2. Evaluation of the Genotype MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. Hillemann D, Rüsch-Gerdes S, Richter E, J Clin Microbiol 2007 45 2635 2640 (Pubitemid 47295497)
3. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD, Lancet 2011 377 1495 1505
4. Genetic diversity of Mycobacterium tuberculosis in Madang, Papua New Guinea. Ballif M, Harino P, Ley S, Carter R, Coulter C, Niemann S, Borrell S, Fenner L, Siba P, Phuanukoonnon S, Gagneux S, Beck H-P, The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 2012 16 1100 1107
5. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, Nicol M, Niemann S, Kremer K, Gutierrez MC, Hilty M, Hopewell PC, Small PM, Proc Natl Acad Sci U S A 2006 103 2869 2873
6. Mechanisms of drug resistance in Mycobacterium tuberculosis [State of the art series. Drug-resistant tuberculosis. Edited by C-Y. Chiang. Number 1 in the series]. Zhang Y, Yew WW, The International Journal of Tuberculosis and Lung Disease 2009 13 1320 1330
7. Gey van Pittius NC, Victor TC, van Helden PD, Warren RM: inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa? Müller B, Streicher EM, Hoek KGP, Tait M, Trollip A, Bosman ME, Coetzee GJ, Chabula-Nxiweni EM, Hoosain E, Int. J. Tuberc. Lung Dis 2011 15 344 351
8. Tuberculosis Drug Resistance Mutation Database. Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, Murray MB, PLoS Med 2009 6 1000002
9. Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, García-García L, Leán CI, Bose M, Chaves F, Murray M, Eisenach KD, Sifuentes-Osornio J, Cave MD, Ponce de Leán A, Alland D: Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis. Hazbán MH, Brimacombe M, Antimicrob Agents Chemother 2006 50 2640 2649
10. Stover CK: Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Sherman DR, Mdluli K, Hickey MJ, Arain TM, Morris SL, Barry CE, Science 1996 272 1641 1643 (Pubitemid 26200020)
11. Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosis. Gagneux S, Burgos MV, DeRiemer K, Enciso A, Mũoz S, Hopewell PC, Small PM, Pym AS, PLoS Pathog 2006 2 61
12. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, Matter L, Schopfer K, Bodmer T, Lancet 1993 341 647 650 (Pubitemid 23083244)
13. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. Van Deun A, Barrera L, Bastian I, Fattorini L, Hoffmann H, Kam KM, Rigouts L, Rüsch-Gerdes S, Wright A, J Clin Microbiol 2009 47 3501 3506
14. Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge. van Ingen J, Aarnoutse R, de Vries G, Boeree MJ, van Soolingen D, Int. J. Tuberc. Lung Dis 2011 15 990 992
15. Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin. Zaczek A, Brzostek A, Augustynowicz-Kopec E, Zwolska Z, Dziadek J, BMC Microbiol 2009 9 10
16. Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan. Hillemann D, Kubica T, Agzamova R, Venera B, Rüsch-Gerdes S, Niemann S, Int. J. Tuberc. Lung Dis 2005 9 1161 1167 (Pubitemid 41433807)
17. The ins and outs of Mycobacterium tuberculosis drug susceptibility testing. Böttger EC, Clin Microbiol Infect 2011 17 1128 1134
18. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Sreevatsan S, Pan X, Stockbauer KE, Williams DL, Kreiswirth BN, Musser JM, Antimicrob Agents Chemother 1996 40 1024 1026 (Pubitemid 26115243)
19. Streptomycin resistance in mycobacteria. Honoré N, Cole ST, Antimicrob Agents Chemother 1994 38 238 242 (Pubitemid 24054240)
20. Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria. Okamoto S, Tamaru A, Nakajima C, Nishimura K, Tanaka Y, Tokuyama S, Suzuki Y, Ochi K, Mol Microbiol 2007 63 1096 1106 (Pubitemid 46188264)
21. Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism. Spies FS, da Silva PEA, Ribeiro MO, Rossetti ML, Zaha A, Antimicrob Agents Chemother 2008 52 2947 2949
22. Mutations in gidB Confer Low-Level Streptomycin Resistance in Mycobacterium tuberculosis. Wong SY, Lee JS, Kwak HK, Via LE, Boshoff HIM, Barry CE, Antimicrob Agents Chemother 2011 55 2515 2522
23. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Comas I, Chakravartti J, Small PM, Galagan J, Niemann S, Kremer K, Ernst JD, Gagneux S, Nat Genet 2010 42 498 503
24. Streptomycin Resistance and Lineage-Specific Polymorphisms in Mycobacterium tuberculosis gidB Gene. Spies FS, Ribeiro AW, Ramos DF, Ribeiro MO, Martin A, Palomino JC, Rossetti MLR, da Silva PEA, Zaha A, J Clin Microbiol 2011 49 2625 2630
25. Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis. Borrell S, Gagneux S, Clin Microbiol Infect 2011 17 815 820
26. A New and Rapid Method for the Isolation and Cultivation of Tubercle Bacilli Directly from the Sputum and Feces. Petroff SA, J Exp Med 1915 21 38 42
27. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA, Bull. World Health Organ 1969 41 21 43
28. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J, J Clin Microbiol 1997 35 907 914 (Pubitemid 27146535)
29. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, Bifani P, Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V, Gutierrez MC, Fauville M, Niemann S, Skuce R, Kremer K, Locht C, van Soolingen D, J Clin Microbiol 2006 44 4498 4510 (Pubitemid 44937085)
30. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. Allix-Béguec C, Harmsen D, Weniger T, Supply P, Niemann S, J Clin Microbiol 2008 46 2692 2699
31. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. Hershberg R, Lipatov M, Small PM, Sheffer H, Niemann S, Homolka S, Roach JC, Kremer K, Petrov DA, Feldman MW, Gagneux S, PLoS Biol 2008 6 311
32. Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies. Comas I, Homolka S, Niemann S, Gagneux S, PLoS One 2009 4 7815
33. Pseudo-Beijing: Evidence for Convergent Evolution in the Direct Repeat Region of Mycobacterium tuberculosis. Fenner L, Malla B, Ninet B, Dubuis O, Stucki D, Borrell S, Huna T, Bodmer T, Egger M, Gagneux S, PLoS One 2011 6 24737